Clinical trial
Assessment of Itraconazole Pharmacokinetic With and Without Efavirenz Using the Capsule Formulation as Part of Talaromycosis Treatment in HIV-infected Adults
NCT04031053 is registered in ClinicalTrials.gov with Chiang Mai University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Itraconazole Pharmacokinetic With and Without Efavirenz Using the Capsule Formulation as Part of Talaromycosis Treatment in HIV-infected Adults
- Lead sponsor
- Chiang Mai University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2019
- Completion date
- April 30, 2021
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
efavirenz, penicilliosis, pharmacokinetics